All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-23386590

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	23386590	C10A	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
2	23386590	C31C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
3	23386590	C31T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
4	23386590	F141L	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
5	23386590	T53C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
6	23386590	A1C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
7	23386590	A1T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
8	23386590	A135C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
9	23386590	A1652G	EnhII		Carcinoma, Hepatocellular	G S C L	View
10	23386590	A1727G	EnhII		Carcinoma, Hepatocellular	G S C L	View
11	23386590	A1727T	EnhII		Carcinoma, Hepatocellular	G S C L	View
12	23386590	A1846T	BCP		Carcinoma, Hepatocellular	G S C L	View
13	23386590	A31C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
14	23386590	A31T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
15	23386590	A52C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
16	23386590	A52T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
17	23386590	C109A	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
18	23386590	C109T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
19	23386590	C1653T	EnhII		Carcinoma, Hepatocellular	G S C L	View
20	23386590	C1673T	EnhII		Carcinoma, Hepatocellular	G S C L	View
21	23386590	C1730G	EnhII		Carcinoma, Hepatocellular	G S C L	View
22	23386590	C1799G	BCP		Carcinoma, Hepatocellular	G S C L	View
23	23386590	C2875A	PreS2	S	Carcinoma, Hepatocellular	G S C L T	View
24	23386590	G105C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
25	23386590	G105T	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
26	23386590	G147C	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
27	23386590	G1719T	EnhII		Carcinoma, Hepatocellular	G S C L	View
28	23386590	G1896A	PreC	C	Carcinoma, Hepatocellular	G S C L	View
29	23386590	T1753C	BCP		Carcinoma, Hepatocellular	G S C L	View
30	23386590	T49A	PreS2	S	Carcinoma, Hepatocellular	G S C L	View
31	23386590	C76A	PreS2	S	Carcinoma, Hepatocellular	G C L T	View
32	23386590	C7A	PreS2	S	Carcinoma, Hepatocellular	G C L T	View
33	23386590	T1753V	BCP		Carcinoma, Hepatocellular	G S C L T	View
34	23386590	A1726C	Core Promoter		Carcinoma, Hepatocellular	G S C L T	View
35	23386590	A1762T	BCP		Carcinoma, Hepatocellular	G S C L	View
36	23386590	G1764A	BCP		Carcinoma, Hepatocellular	G S C L T	View
37	23386590	T1674C	Core Promoter		Carcinoma, Hepatocellular	G S C L T	View
38	23386590	T1674G	Core Promoter		Carcinoma, Hepatocellular	G S C L T	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.